Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02390856 · ClinicalTrials.gov registry record · NA

Volar Plate vs. Conventus DRS Fixation

A NA study, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT02390856: Completed NA study, sponsored by Hospital for Special Surgery, New York.

NCT02390856 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02390856, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

Open reduction and internal fixation (ORIF) of unstable distal radius fractures is performed using a variety of fixation techniques. The most common method is fixed angle volar plate application. The investigators plan to compare the outcomes of fixed angle volar plating with a novel FDA approved intramedullary fixation device, Conventus DRS.

Primary Outcome

Patients will be followed for up to one year after surgery to assess any complications which may develop. Complications will be defined as: * Stiffness (defined as inability to touch fingertips to distal palmar crease, OR 45 degrees or more loss of supination or pronation \[compared to uninjured wrist\], OR BOTH) * Loss of reduction * Hardware breakage * Hardware removal * Return to OR * Tendinopathy * Tendon rupture * Neuropathy * Superficial infection * Deep infection * Wound dehiscence * Inc

Interventions

  • DEVICE Conventus DRS
  • DEVICE Volar Plate

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2015-02
Est. Completion 2018-12
Phase NA

What the finished NCT02390856 record still lists

NCT02390856 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Conventus DRS is the first listed.

NCT02390856 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02390856 about?

NCT02390856 is a clinical study titled "Volar Plate vs. Conventus DRS Fixation". Open reduction and internal fixation (ORIF) of unstable distal radius fractures is performed using a variety of fixation techniques. The most common method is fixed angle volar plate application. The investigators plan to compare the outcomes of fixed angle volar plating with a novel FDA approved in...

What is the current status of trial NCT02390856?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-02. Estimated completion is 2018-12.

What interventions are being tested in trial NCT02390856?

The interventions under investigation include: Conventus DRS (DEVICE), Volar Plate (DEVICE).

Who is sponsoring clinical trial NCT02390856?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02390856's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02390856, the US trial registry maintained by the National Library of Medicine. NCT02390856 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.